New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Aligos Therapeutics, Inc. (ALGS) vs Dare Bioscience, Inc. (DARE)
- Aligos Therapeutics, Inc. ALGS 1.22 −2.40%
- Dare Bioscience, Inc. DARE 0.41 −8.89%
Aligos Therapeutics, Inc. and Dare Bioscience, Inc. are both Biotechnology companies. Aligos Therapeutics, Inc. and Dare Bioscience, Inc. are of similar size ($8.9M and $8.8M). Dare Bioscience, Inc. grew revenue faster over the last twelve months: 2,571.6% against 1,171.6%. Aligos Therapeutics, Inc. has the higher net margin (−197.0% vs −749.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Aligos Therapeutics, Inc. leads on 10 and Dare Bioscience, Inc. on 5.
Valuation
Profitability
| Metric | ALGS | DARE | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 47.37% | 70.18% |
| Operating margin | (215.55%) | (746.14%) | 0.00% |
| Net margin | (197.01%) | (749.83%) | 0.00% |
| Free cash flow margin | (204.07%) | — | 0.00% |
| Return on equity | (159.46%) | (407.13%) | (51.58%) |
| Return on assets | (84.46%) | (40.05%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack